UK markets closed

Acorda Therapeutics, Inc. (ACOR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.66100.0000 (0.00%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
117,633
117,633
118,566
129,071
152,967
Cost of revenue
15,283
15,283
30,332
40,787
33,513
Gross profit
102,350
102,350
88,234
88,284
119,454
Operating expenses
Research development
5,152
5,152
5,804
10,420
23,012
Selling general and administrative
89,698
89,698
106,256
124,399
152,576
Total operating expenses
125,614
125,614
130,270
165,583
206,351
Operating income or loss
-23,264
-23,264
-42,036
-77,299
-86,897
Interest expense
31,533
31,533
30,200
30,035
30,574
Total other income/expenses net
-241,754
-241,754
35,080
-1,745
8,988
Income before tax
-296,021
-296,021
-35,247
-109,074
-107,667
Income tax expense
-43,167
-43,167
30,669
-5,120
-8,073
Income from continuing operations
-252,854
-252,854
-65,916
-103,954
-99,594
Net income
-252,854
-252,854
-65,916
-103,954
-99,594
Net income available to common shareholders
-252,854
-252,854
-65,916
-103,954
-99,594
Basic EPS
2.61
-203.57
-65.23
-195.80
-246.40
Diluted EPS
2.61
-203.57
-65.23
-195.80
-246.40
Basic average shares
1,264
1,242
1,011
531.05
404.2
Diluted average shares
1,264
1,242
1,011
531.05
404.2